Endo USA, Inc. - NDC products
NDC labeler, manufacturer of drugs and pharmaceuticals
Products with assigned NDCs are displayed. Select the NDC to see product information. Select the Trade Name to see similar products.
Hide deleted NDCs:
NDC | Trade Name | Labeler Name | Deleted | Deleted Date |
---|---|---|---|---|
00254-1007 | Albuterol Sulfate | Par Pharmaceutical Inc. | Yes | 2022-12-31 |
00254-3012 | ALVIMOPAN | ENDO USA, Inc. | No | |
00254-2053 | Chlorzoxazone | Endo USA, Inc. | No | |
00254-2005 | Chlorzoxazone | Endo USA, Inc. | No | |
00254-0460 | Colchicine | Endo USA, Inc. | No | |
00254-2008 | Colchicine | Par Pharmaceutical, Inc. | Yes | No later than 2025-03-24 |
00254-1010 | Diazoxide | Endo USA, Inc. | No | |
00254-2033 | EMOQUETTE | Par Pharmaceutical, Inc. | Yes | No later than 2024-12-19 |
00254-1021 | Erythromycin Ethylsuccinate | Par Pharmaceutical, Inc. | Yes | 2021-09-30 |
00254-1020 | Erythromycin Ethylsuccinate | Par Pharmaceutical, Inc. | Yes | 2021-11-30 |
00254-2034 | Hydrocodone Bitartrate and Acetaminophen | Par Pharmaceutical, Inc. | Yes | No later than 2024-12-19 |
00254-2035 | Hydrocodone Bitartrate and Acetaminophen | Par Pharmaceutical, Inc. | Yes | No later than 2024-12-19 |
00254-2036 | Hydrocodone Bitartrate and Acetaminophen | Par Pharmaceutical, Inc. | Yes | No later than 2024-12-19 |
00254-3029 | Lubiprostone | Endo USA, Inc. | No | |
00254-3028 | Lubiprostone | Endo USA, Inc. | No | |
00254-3022 | Nitisinone | Endo USA, Inc. | No | |
00254-3021 | Nitisinone | Endo USA, Inc. | No | |
00254-3020 | Nitisinone | Endo USA, Inc. | No | |
00254-3010 | Omega-3-acid ethyl esters | Par Pharmaceutical Inc. | No | |
00254-2032 | Orsythia | Par Pharmaceutical, Inc. | Yes | No later than 2022-12-30 |
00254-2000 | penicillamine | Endo USA, Inc. | No | |
00254-2045 | POSACONAZOLE | ENDO USA, Inc. | No | |
00254-1016 | POSACONAZOLE | ENDO USA, Inc. | No | |
00254-2029 | Previfem | Par Pharmaceutical, Inc. | Yes | 2022-06-30 |
00254-1011 | Sucralfate | Par Pharmaceutical Inc. | Yes | 2025-02-28 |
00254-1012 | Testosterone | Par Pharmaceutical, Inc. | Yes | 2021-09-30 |
00254-3034 | TIOPRONIN | Endo USA, Inc. | No | |
00254-3035 | TIOPRONIN | Endo USA, Inc. | No | |
00254-2030 | Tri-Previfem | Par Pharmaceutical, Inc. | Yes | 2022-03-31 |
00603-2337 | Acetaminophen And Codeine | Par Pharmaceutical, Inc. | Yes | 2022-01-31 |
00603-2338 | Acetaminophen And Codeine | Par Pharmaceutical, Inc. | Yes | 2022-02-28 |
00603-2339 | Acetaminophen And Codeine | Par Pharmaceutical, Inc. | Yes | 2022-02-28 |
00603-9013 | Acetaminophen And Codeine | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-1020 | acetaminophen and codeine phosphate | Qualitest Pharmaceuticals | Yes | No later than 2015-06-29 |
00603-7038 | Acetic Acid | Qualitest Pharmaceuticals | Yes | 2017-05-31 |
00603-1008 | Albuterol Sulfate | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-2115 | Allopurinol | Endo USA, Inc. | No | |
00603-2116 | Allopurinol | Endo USA, Inc. | No | |
00603-2127 | Alprazolam | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-2128 | Alprazolam | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-2129 | Alprazolam | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-2130 | Alprazolam | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-2131 | Alprazolam Extended-Release | Qualitest Pharmaceuticals | Yes | No later than 2012-09-28 |
00603-2132 | Alprazolam Extended-Release | Qualitest Pharmaceuticals | Yes | No later than 2012-09-28 |
00603-2133 | Alprazolam Extended-Release | Qualitest Pharmaceuticals | Yes | No later than 2012-09-28 |
00603-2134 | Alprazolam Extended-Release | Qualitest Pharmaceuticals | Yes | No later than 2012-09-28 |
00603-1011 | Amantadine Hydrochloride | Qualitest Pharmaceuticals | Yes | No later than 2015-12-16 |
00603-2212 | Amitriptyline Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
00603-2213 | Amitriptyline Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
00603-2214 | Amitriptyline Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
00603-2215 | Amitriptyline Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
00603-2216 | Amitriptyline Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
00603-2217 | Amitriptyline Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
00603-2108 | Amlodipine Besylate | Par Pharmaceutical | Yes | 2019-04-30 |
00603-2109 | Amlodipine Besylate | Par Pharmaceutical | Yes | 2019-06-30 |
00603-2110 | Amlodipine Besylate | Par Pharmaceutical | Yes | 2019-05-31 |
00603-0024 | Aspirin | Qualitest Pharmaceuticals | Yes | No later than 2019-06-25 |
00603-0168 | Aspirin | Qualitest Pharmaceutical, Inc. | Yes | No later than 2020-12-31 |
00603-0441 | Bacitracin zinc | Qualitest Pharmaceuticals | Yes | 2018-05-31 |
00603-2406 | Baclofen | Endo USA, Inc. | No | |
00603-2407 | Baclofen | Endo USA, Inc. | No | |
00603-2433 | Benztropine Mesylate | Endo USA, Inc. | Yes | 2019-09-30 |
00603-2434 | Benztropine Mesylate | Endo USA, Inc. | Yes | 2019-09-30 |
00603-2435 | Benztropine Mesylate | Endo USA, Inc. | Yes | 2019-09-30 |
00603-2437 | Benztropine Mesylate | Par Pharmaceutical, Inc. | Yes | 2024-05-31 |
00603-2438 | Benztropine Mesylate | Par Pharmaceutical, Inc. | Yes | 2024-06-30 |
00603-2439 | Benztropine Mesylate | Par Pharmaceutical, Inc. | Yes | 2024-06-30 |
00603-2483 | Bisacodyl | Qualitest Pharmaceuticals | Yes | No later than 2017-12-29 |
00603-2540 | butalbital and acetaminophen | Endo USA | No | |
00603-2544 | Butalbital, Acetaminophen and Caffeine | Par Pharmaceutical, Inc. | Yes | 2024-03-31 |
00603-2545 | Butalbital, Acetaminophen and Caffeine | Qualitest Pharmaceuticals | Yes | No later than 2014-03-31 |
00603-2553 | Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate | Par Pharmaceutical, Inc. | Yes | 2022-09-30 |
00603-2548 | Butalbital, Aspirin and Caffeine Tablets | Qualitest | Yes | No later than 2015-12-16 |
00603-2582 | Carisoprodol | Par Pharmaceutical | Yes | 2020-06-30 |
00603-9063 | Cetirizine Hydrochloride | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-1075 | Cheratussin AC | Par Pharmaceutical | Yes | 2020-03-31 |
00603-1078 | Cheratussin DAC | Qualitest Pharmaceuticals | Yes | No later than 2017-12-29 |
00603-0839 | Childrens QPAP | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0840 | Childrens QPAP | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0841 | Childrens QPAP | Qualitest Pharmaceuticals | Yes | 2018-04-30 |
00603-0842 | Childrens QPAP | Qualitest Pharmaceuticals | Yes | 2018-04-30 |
00603-0843 | Childrens QPAP | Qualitest Pharmaceuticals | Yes | 2018-05-31 |
00603-1096 | Clemastine Fumarate | Qualitest Pharmaceuticals, Inc | Yes | No later than 2017-04-03 |
00603-1086 | CLINDAMYCIN PHOSPHATE | Qualitest Pharmaceuticals | Yes | No later than 2017-12-29 |
00603-2948 | Clonazepam | Qualitest Pharmaceuticals | Yes | 2019-09-30 |
00603-2949 | Clonazepam | Qualitest Pharmaceuticals | Yes | 2018-02-28 |
00603-2950 | Clonazepam | Qualitest Pharmaceuticals | Yes | 2018-04-30 |
00603-2957 | Clonidine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2018-09-23 |
00603-2958 | Clonidine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2017-07-31 |
00603-2959 | Clonidine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2017-07-31 |
00603-0728 | Codituss DM | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-7521 | Cyclafem 1/35 | Par Pharmaceutical, Inc. | Yes | 2022-04-30 |
00603-7525 | Cyclafem 7/7/7 | Par Pharmaceutical, Inc. | Yes | 2022-04-30 |
00603-3078 | Cyclobenzaprine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2018-07-31 |
00603-3079 | Cyclobenzaprine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2018-10-31 |
00603-1147 | Dexamethasone | Qualitest Pharmaceuticals | Yes | 2017-07-31 |
00603-2674 | Dextroamphetamine Sulfate | Par Pharmaceutical | Yes | No later than 2019-03-18 |
00603-2675 | Dextroamphetamine Sulfate | Par Pharmaceutical | Yes | No later than 2019-03-18 |
00603-2676 | Dextroamphetamine Sulfate | Par Pharmaceutical | Yes | No later than 2019-03-18 |
00603-3213 | Diazepam | Qualitest Pharmaceuticals | Yes | 2018-03-31 |
00603-3214 | Diazepam | Qualitest Pharmaceuticals | Yes | 2017-10-31 |
00603-3215 | Diazepam | Qualitest Pharmaceuticals | Yes | 2019-08-31 |
00603-1161 | dicyclomine hydrochloride | Endo USA, Inc. | No | |
00603-3327 | Dimenhydrinate | Qualitest Pharmaceuticals | Yes | 2016-08-31 |
00603-3330 | Dimenhydrinate | Qualitest Pharmaceuticals | Yes | 2017-12-31 |
00603-3339 | Diphenhydramine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2020-03-30 |
00603-3340 | Diphenhydramine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2018-06-30 |
00603-3432 | Disulfiram | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-3433 | Disulfiram | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-3441 | Divalproex Sodium Delayed-Release | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-3442 | Divalproex Sodium Delayed-Release | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-3443 | Divalproex Sodium Delayed-Release | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0746 | Doc Q Lace | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0145 | DocQLace | Qualitest Pharmaceuticals | Yes | 2013-11-01 |
00603-0150 | DocQLace | Par Pharmaceutical | Yes | 2021-12-31 |
00603-0747 | DocQLace | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0149 | DocQLax | Par Pharmaceutical | Yes | 2020-05-31 |
00603-3508 | Effervescent Potassium Chloride | Qualitest Pharmaceuticals | Yes | 2021-07-31 |
00603-7540 | Emoquette | Par Pharmaceutical | Yes | 2019-12-31 |
00603-0169 | Enteric Coated Aspirin | Qualitest Pharmaceuticals | Yes | No later than 2019-03-18 |
00603-0265 | Extra Strength QPap | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0268 | Extra Strength QPAP | Qualitest Pharmaceuticals | Yes | 2018-07-31 |
00603-3581 | Felodipine | Endo USA, Inc. | No | |
00603-3582 | Felodipine | Endo USA, Inc. | No | |
00603-3583 | Felodipine | Endo USA, Inc. | No | |
00603-0179 | FERROUS SULFATE | Qualitest Pharmaceuticals | Yes | 2020-03-30 |
00603-0181 | FiberTab | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-3633 | Finasteride | Qualitest Pharmaceuticals | Yes | 2018-02-28 |
00603-3162 | Folic Acid | Par Pharmaceutical | Yes | 2021-07-31 |
00603-3714 | Folic Acid | Qualitest | Yes | No later than 2015-12-16 |
00603-3718 | Frovatriptan Succinate | Endo USA, Inc. | No | |
00603-3739 | Furosemide | Qualitest Pharmaceuticals | Yes | 2018-09-30 |
00603-3740 | Furosemide | Qualitest Pharmaceuticals | Yes | 2018-09-30 |
00603-3741 | Furosemide | Qualitest Pharmaceuticals | Yes | 2018-07-31 |
00603-3590 | Gildagia | Par Pharmaceutical | Yes | No later than 2019-03-18 |
00603-7606 | Gildess 1.5/30 | Par Pharmaceutical | Yes | 2018-03-31 |
00603-7607 | Gildess 1/20 | Par Pharmaceutical | Yes | 2018-03-31 |
00603-7610 | Gildess 24 Fe | Qualitest Pharmaceuticals | Yes | No later than 2017-12-29 |
00603-7608 | GILDESS FE 1.5/30 | Par Pharmaceutical | Yes | 2018-01-31 |
00603-7609 | GILDESS FE 1/20 | Par Pharmaceutical | Yes | 2018-01-31 |
00603-3744 | Glimepiride | Qualitest Pharmaceuticals | Yes | 2018-09-22 |
00603-3745 | Glimepiride | Qualitest Pharmaceuticals | Yes | 2018-04-30 |
00603-3746 | Glimepiride | Qualitest Pharmaceuticals | Yes | 2018-09-22 |
00603-3180 | Glycopyrrolate | Qualitest Pharmaceuticals | Yes | 2017-05-31 |
00603-3181 | Glycopyrrolate | Qualitest Pharmaceuticals | Yes | 2017-06-30 |
00603-9171 | Griseofulvin | Qualitest Pharmaceuticals | Yes | 2018-02-28 |
00603-1290 | Haloperidol | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0520 | Hemorrhoidal | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0524 | HEMORRHOIDAL RECTAL | Generics Bidco I, LLC dba Qualitest Pharmaceuticals | Yes | No later than 2015-12-16 |
00603-3855 | Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2018-03-31 |
00603-3856 | Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2018-09-26 |
00603-3857 | Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2018-09-22 |
00603-1295 | Hydrocodone Bitartrate and Acetaminophen | Qualitest Pharmaceuticals | Yes | No later than 2014-03-31 |
00603-3609 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | Par Pharmaceutical | Yes | 2019-01-31 |
00603-3880 | Hydrocodone Bitartrate And Acetaminophen | Qualitest Pharmaceuticals | Yes | 2013-12-31 |
00603-3881 | Hydrocodone Bitartrate And Acetaminophen | Qualitest Pharmaceuticals | Yes | 2013-12-31 |
00603-3882 | Hydrocodone Bitartrate And Acetaminophen | Qualitest Pharmaceuticals | Yes | 2013-12-31 |
00603-3883 | Hydrocodone Bitartrate And Acetaminophen | Qualitest Pharmaceuticals | Yes | 2013-12-31 |
00603-3884 | Hydrocodone Bitartrate And Acetaminophen | Qualitest Pharmaceuticals | Yes | 2013-12-31 |
00603-3885 | Hydrocodone Bitartrate And Acetaminophen | Qualitest Pharmaceuticals | Yes | 2013-12-31 |
00603-3886 | Hydrocodone Bitartrate And Acetaminophen | Qualitest Pharmaceuticals | Yes | 2013-12-31 |
00603-3887 | Hydrocodone Bitartrate And Acetaminophen | Par Pharmaceutical, Inc. | Yes | 2023-09-30 |
00603-3888 | Hydrocodone Bitartrate And Acetaminophen | Qualitest Pharmaceuticals | Yes | 2013-12-31 |
00603-3890 | Hydrocodone Bitartrate And Acetaminophen | Par Pharmaceutical, Inc. | Yes | 2022-11-30 |
00603-3891 | Hydrocodone Bitartrate And Acetaminophen | Par Pharmaceutical, Inc. | Yes | 2022-11-30 |
00603-3584 | Hydrocodone Bitartrate and Ibuprofen | Par Pharmaceutical | Yes | No later than 2021-07-01 |
00603-3586 | Hydrocodone Bitartrate and Ibuprofen | Par Pharmaceutical, Inc. | Yes | 2022-05-31 |
00603-3897 | Hydrocodone Bitartrate and Ibuprofen | Par Pharmaceutical | Yes | No later than 2021-07-01 |
00603-0535 | Hydrocortisone | Par Pharmaceutical | Yes | 2020-10-31 |
00603-3899 | Hydrocortisone | Par Pharmaceutical | Yes | 2019-09-30 |
00603-3900 | Hydrocortisone | Par Pharmaceutical | Yes | 2019-10-31 |
00603-3901 | Hydrocortisone | Par Pharmaceutical | Yes | 2019-09-30 |
00603-7781 | Hydrocortisone | Par Pharmaceutical | Yes | 2020-08-31 |
00603-7784 | Hydrocortisone | Qualitest Pharmaceuticals Inc. | Yes | No later than 2013-06-28 |
00603-7785 | Hydrocortisone | Par Pharmaceutical | Yes | 2018-12-31 |
00603-7039 | Hydrocortisone and Acetic Acid | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-1310 | Hydroxyzine Hydrochloride | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-3967 | Hydroxyzine Hydrochloride | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-3968 | Hydroxyzine Hydrochloride | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-3969 | Hydroxyzine Hydrochloride | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4021 | Ibuprofen | Qualitest Pharmaceuticals | Yes | No later than 2015-12-16 |
00603-4022 | Ibuprofen | Qualitest Pharmaceuticals | Yes | No later than 2015-12-16 |
00603-4023 | Ibuprofen | Qualitest Pharmaceuticals | Yes | No later than 2015-12-16 |
00603-0894 | Infants Simethicone | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-1329 | Iophen C NR | Qualitest Pharmaceuticals | Yes | 2017-12-31 |
00603-1330 | Iophen DM NR | Qualitest Pharmaceuticals | Yes | 2018-08-29 |
00603-1328 | Iophen NR | Qualitest Pharmaceuticals | Yes | 2018-07-20 |
00603-4080 | Irbesartan | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4081 | Irbesartan | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4082 | Irbesartan | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4088 | Irbesartan and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-09-30 |
00603-4089 | Irbesartan and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-05-31 |
00603-4110 | Isosorbide Mononitrate | Par Pharmaceutical | Yes | 2019-10-31 |
00603-4111 | Isosorbide Mononitrate | Par Pharmaceutical | Yes | 2019-10-31 |
00603-4112 | Isosorbide Mononitrate | Par Pharmaceutical | Yes | 2019-10-31 |
00603-4170 | K-EFFERVESCENT | Qualitest Pharmaceuticals | Yes | No later than 2020-04-01 |
00603-7512 | Kimidess | Par Pharmaceutical | Yes | 2021-01-31 |
00603-1378 | Lactulose | Par Pharmaceutical | Yes | 2019-10-31 |
00603-4180 | Letrozole | Qualitest Pharmaceuticals | Yes | 2015-09-30 |
00603-1384 | Levetiracetam | Par Pharmaceutical | Yes | 2019-05-31 |
00603-3842 | Levetiracetam | Qualitest Pharmaceuticals | Yes | No later than 2015-06-29 |
00603-3843 | Levetiracetam | Qualitest Pharmaceuticals | Yes | No later than 2015-06-29 |
00603-3844 | Levetiracetam | Qualitest Pharmaceuticals | Yes | No later than 2015-06-29 |
00603-3845 | Levetiracetam | Qualitest Pharmaceuticals | Yes | No later than 2015-06-29 |
00603-4186 | Levetiracetam | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4187 | Levetiracetam | Qualitest Pharmaceuticals | Yes | 2017-07-31 |
00603-1880 | Lidocaine | Endo USA, Inc. | No | |
00603-1393 | Lidocaine Hydrochloride | Par Pharmaceutical | Yes | 2018-05-31 |
00603-1394 | Lidocaine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2017-06-30 |
00603-4209 | Lisinopril | Par Pharmaceutical | Yes | 2019-03-31 |
00603-4210 | Lisinopril | Par Pharmaceutical | Yes | 2019-04-30 |
00603-4211 | Lisinopril | Par Pharmaceutical | Yes | 2019-03-31 |
00603-4212 | Lisinopril | Par Pharmaceutical | Yes | 2019-04-30 |
00603-4213 | Lisinopril | Par Pharmaceutical | Yes | 2019-02-28 |
00603-4214 | Lisinopril | Par Pharmaceutical | Yes | 2019-04-30 |
00603-4246 | Lorazepam | Qualitest Pharmaceuticals | Yes | 2020-05-30 |
00603-4247 | Lorazepam | Qualitest Pharmaceuticals | Yes | 2018-07-19 |
00603-4248 | Lorazepam | Qualitest Pharmaceuticals | Yes | 2018-05-31 |
00603-4224 | Losartan Potassium | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4225 | Losartan Potassium | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4226 | Losartan Potassium | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4228 | Losartan Potassium and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-07-31 |
00603-4229 | Losartan Potassium and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-07-31 |
00603-4230 | Losartan Potassium and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-08-31 |
00603-0026 | Low Dose Aspirin | Qualitest Pharmaceuticals | Yes | No later than 2019-03-18 |
00603-0209 | Magnesium Oxide | Endo USA | No | |
00603-0213 | Magnesium Oxide | Endo USA | No | |
00603-0211 | MAXIMUM STRENGTH MYTAB For GAS | Qualitest Pharmaceuticals | Yes | No later than 2019-03-18 |
00603-4372 | Mefenamic Acid | Qualitest Pharmaceuticals | Yes | 2017-07-31 |
00603-4415 | Meperidine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2018-02-28 |
00603-4416 | Meperidine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2017-07-31 |
00603-1422 | Metaproterenol Sulfate | Qualitest Pharmaceuticals, Inc, | Yes | No later than 2017-04-03 |
00603-4467 | Metformin Hydrochloride | Qualitest Pharmaceuticals | Yes | No later than 2015-06-29 |
00603-4468 | Metformin Hydrochloride | Qualitest Pharmaceuticals | Yes | No later than 2015-06-29 |
00603-4469 | Metformin Hydrochloride | Qualitest Pharmaceuticals | Yes | No later than 2015-06-29 |
00603-4485 | Methocarbamol | Par Pharmaceutical | Yes | No later than 2019-12-28 |
00603-4486 | Methocarbamol | Par Pharmaceutical | Yes | No later than 2019-12-28 |
00603-4576 | Methylphenidate Hydrochloride | Par Pharmaceutical | Yes | 2021-02-28 |
00603-4577 | Methylphenidate Hydrochloride | Par Pharmaceutical | Yes | 2021-05-31 |
00603-4578 | Methylphenidate Hydrochloride | Par Pharmaceutical | Yes | 2021-04-30 |
00603-4593 | MethylPREDNISolone | Endo USA, Inc. | No | |
00603-4614 | Metoclopramide | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4615 | Metoclopramide | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-7805 | Miconazole Nitrate | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4661 | Modafinil | Qualitest Pharmaceuticals | Yes | 2017-06-30 |
00603-4662 | Modafinil | Qualitest Pharmaceuticals | Yes | 2017-06-30 |
00603-4653 | Montelukast Sodium | Par Pharmaceutical | Yes | 2020-01-31 |
00603-4654 | Montelukast Sodium | Par Pharmaceutical | Yes | 2020-01-31 |
00603-4655 | Montelukast Sodium | Par Pharmaceutical | Yes | 2019-10-31 |
00603-1445 | Morphine Sulfate | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-1446 | Morphine Sulfate | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4381 | Multi Vitamin with Fluoride | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4382 | Multi Vitamin with Fluoride | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4383 | Multi Vitamin with Fluoride | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-1449 | Multi-Vit with Fluoride | Par Pharmaceutical | Yes | 2021-03-31 |
00603-1450 | Multi-Vit with Fluoride | Par Pharmaceutical | Yes | 2021-03-31 |
00603-1452 | Multi-Vit with Fluoride and Iron | Par Pharmaceutical | Yes | 2021-02-28 |
00603-0210 | MYTAB For GAS | Qualitest Pharmaceuticals | Yes | No later than 2019-03-18 |
00603-7625 | Myzilra | Par Pharmaceutical | Yes | 2019-12-31 |
00603-1481 | Nystatin | Par Pharmaceutical | Yes | 2019-04-30 |
00603-7818 | Nystatin | Par Pharmaceutical | Yes | 2021-07-31 |
00603-4890 | ORGAN I NR | Par Pharmaceutical | Yes | 2018-12-31 |
00603-4886 | ORGAN-I NR | Qualitest Pharmaceuticals | Yes | 2016-10-31 |
00603-7634 | Orsythia | Par Pharmaceutical | Yes | 2019-12-31 |
00603-1491 | Oxybutynin Chloride | Qualitest Pharmaceuticals | Yes | 2018-01-31 |
00603-4975 | Oxybutynin Chloride | Par Pharmaceutical, Inc. | Yes | 2023-12-31 |
00603-4978 | Oxycodone and Acetaminophen | Par Pharmaceutical, Inc. | Yes | 2021-10-31 |
00603-4979 | Oxycodone and Acetaminophen | Par Pharmaceutical, Inc. | Yes | 2021-10-31 |
00603-4982 | Oxycodone and Acetaminophen | Par Pharmaceutical, Inc. | Yes | 2021-10-31 |
00603-4998 | Oxycodone and Acetaminophen | Par Pharmaceutical | Yes | No later than 2021-07-01 |
00603-4990 | Oxycodone Hydrochloride | Par Pharmaceutical | Yes | 2019-11-30 |
00603-4991 | Oxycodone Hydrochloride | Par Pharmaceutical | Yes | 2020-02-29 |
00603-4992 | Oxycodone Hydrochloride | Par Pharmaceutical | Yes | 2020-02-29 |
00603-4993 | Oxycodone Hydrochloride | Par Pharmaceutical | Yes | 2020-02-29 |
00603-4994 | Oxycodone Hydrochloride | Par Pharmaceutical | Yes | 2020-02-29 |
00603-1492 | Oxycodone Hydrochloride and Acetaminophen | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-4997 | Oxycodone Hydrochloride and Acetaminophen | Qualitest Pharmaceuticals | Yes | No later than 2014-03-31 |
00603-5060 | Perphenazine | Endo USA, Inc. | No | |
00603-5061 | Perphenazine | Endo USA, Inc. | No | |
00603-5062 | Perphenazine | Endo USA, Inc. | No | |
00603-5063 | Perphenazine | Endo USA, Inc. | No | |
00603-5090 | Perphenazine | Qualitest Pharmaceuticals | Yes | No later than 2015-03-31 |
00603-5091 | Perphenazine | Qualitest Pharmaceuticals | Yes | No later than 2015-03-31 |
00603-5092 | Perphenazine | Qualitest Pharmaceuticals | Yes | No later than 2015-03-31 |
00603-5093 | Perphenazine | Qualitest Pharmaceuticals | Yes | No later than 2015-03-31 |
00603-1508 | Phenobarbital | Par Pharmaceutical | Yes | 2024-02-29 |
00603-5165 | Phenobarbital | Endo USA, Inc. | No | |
00603-5166 | Phenobarbital | Endo USA, Inc. | No | |
00603-5167 | Phenobarbital | Endo USA, Inc. | No | |
00603-5168 | Phenobarbital | Endo USA, Inc. | No | |
00603-5192 | Phentermine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2017-07-31 |
00603-1520 | Phenylhistine DH | Qualitest Pharmaceuticals | Yes | 2018-04-30 |
00603-0235 | Pink Bismuth | Qualitest Pharmaceuticals | Yes | No later than 2019-03-18 |
00603-1532 | Potassium Chloride | Qualitest Pharmaceuticals | Yes | 2017-02-28 |
00603-1534 | Potassium Chloride | Qualitest Pharmaceuticals | Yes | 2016-08-31 |
00603-1535 | Potassium Chloride | Qualitest Pharmaceuticals | Yes | 2016-09-30 |
00603-1536 | Potassium Chloride | Qualitest Pharmaceuticals | Yes | 2016-08-31 |
00603-1542 | Potassium Chloride | Endo USA, Inc. | Yes | 2026-09-30 |
00603-1543 | Potassium Chloride | Endo USA, Inc. | Yes | 2026-07-31 |
00603-1554 | Potassium Chloride | Endo USA, Inc. | No | |
00603-1550 | Povidone Iodine | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0599 | Povidone-Iodine | Qualitest Pharmaceuticals | Yes | 2018-03-15 |
00603-1567 | PrednisoLONE | Par Pharmaceutical | Yes | 2019-06-30 |
00603-9388 | Prednisolone Sodium Phosphate | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5335 | Prednisone | Endo USA, Inc. | No | |
00603-5336 | Prednisone | Endo USA, Inc. | No | |
00603-5337 | Prednisone | Endo USA, Inc. | No | |
00603-5338 | Prednisone | Endo USA, Inc. | No | |
00603-5339 | Prednisone | Endo USA, Inc. | No | |
00603-7642 | Previfem | Par Pharmaceutical | Yes | 2020-02-29 |
00603-5371 | Primidone | Par Pharmaceutical | Yes | 2021-10-31 |
00603-5372 | Primidone | Par Pharmaceutical | Yes | 2021-09-30 |
00603-1586 | PROMETHAZINE DM | Par Pharmaceutical | Yes | 2020-08-21 |
00603-1584 | Promethazine Hydrochloride | Par Pharmaceutical | Yes | 2021-05-31 |
00603-5437 | Promethazine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2018-05-31 |
00603-5438 | Promethazine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2018-04-30 |
00603-5439 | Promethazine Hydrochloride | Qualitest Pharmaceuticals | Yes | 2018-09-28 |
00603-1587 | Promethazine VC | Par Pharmaceutical | Yes | 2019-10-31 |
00603-1588 | Promethazine VC with Codeine | Par Pharmaceutical | Yes | No later than 2019-10-01 |
00603-1585 | Promethazine with Codeine | Par Pharmaceutical | Yes | 2021-05-31 |
00603-5448 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
00603-5449 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2024-04-30 |
00603-5450 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2024-03-31 |
00603-5482 | Propranolol Hydrochloride | Endo USA, Inc. | No | |
00603-5483 | Propranolol Hydrochloride | Endo USA, Inc. | No | |
00603-5484 | Propranolol Hydrochloride | Endo USA, Inc. | No | |
00603-5485 | Propranolol Hydrochloride | Endo USA, Inc. | No | |
00603-5486 | Propranolol Hydrochloride | Endo USA, Inc. | No | |
00603-0851 | Q Tapp Cold and Allergy | Qualitest Pharmaceuticals | Yes | 2017-09-30 |
00603-0852 | Q Tapp Cold and Cough | Qualitest Pharmaceuticals | Yes | 2018-01-31 |
00603-0855 | Q Tussin DM | Qualitest Pharmaceuticals | Yes | 2018-03-31 |
00603-0241 | Q-DRYL | Qualitest Pharmaceuticals | Yes | 2018-05-31 |
00603-0863 | Q-Tapp | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0864 | Q-Tapp DM Elixir | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0823 | Qdryl Allergy | Qualitest Pharmaceuticals | Yes | 2019-10-31 |
00603-0838 | QPAP Infants Drops | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0857 | QTussin | Qualitest Pharmaceuticals | Yes | 2018-07-20 |
00603-0860 | Quenalin Cough | Qualitest Pharmaceuticals, Inc | Yes | No later than 2017-04-03 |
00603-9418 | Ranitidine | Par Pharmaceutical | Yes | 2018-03-31 |
00603-0263 | Regular Strength QPAP | Qualitest Pharmaceuticals | Yes | 2018-07-31 |
00603-5683 | Risperidone | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5684 | Risperidone | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5685 | Risperidone | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5686 | Risperidone | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5688 | Risperidone | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5689 | Risperidone | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-9424 | Risperidone | Par Pharmaceutical | Yes | 2019-07-31 |
00603-0282 | Senna-Lax | Par Pharmaceutical | Yes | 2022-02-28 |
00603-0283 | SennaLax-S | Par Pharmaceutical | Yes | 2020-06-30 |
00603-5769 | Sotalol Hydrochloride | Par Pharmaceutical | Yes | 2019-06-30 |
00603-5770 | Sotalol Hydrochloride | Par Pharmaceutical | Yes | 2019-03-31 |
00603-5771 | Sotalol Hydrochloride | Par Pharmaceutical | Yes | 2019-03-31 |
00603-5772 | Sotalol Hydrochloride | Par Pharmaceutical | Yes | 2019-03-31 |
00603-5763 | Spironolactone | Par Pharmaceutical | Yes | 2021-07-31 |
00603-5764 | Spironolactone | Par Pharmaceutical | Yes | 2021-04-30 |
00603-5765 | Spironolactone | Par Pharmaceutical | Yes | 2021-07-31 |
00603-1684 | Sulfamethoxazole and Trimethoprim | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-1685 | Sulfamethoxazole and Trimethoprim | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5780 | Sulfamethoxazole and Trimethoprim | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5781 | Sulfamethoxazole and Trimethoprim | Qualitest Pharmaceuticals | Yes | 2018-01-17 |
00603-5801 | Sulfasalazine | Par Pharmaceutical | Yes | 2019-07-31 |
00603-5803 | Sulfasalazine Delayed-Release | Qualitest Pharmaceuticals | Yes | 2018-09-30 |
00603-5914 | Telmisartan | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5915 | Telmisartan | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5916 | Telmisartan | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-5926 | Telmisartan and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-08-31 |
00603-5927 | Telmisartan and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-09-30 |
00603-5928 | Telmisartan and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-08-31 |
00603-5891 | Temazepam | Qualitest Pharmaceuticals | Yes | 2018-01-31 |
00603-5892 | Temazepam | Qualitest Pharmaceuticals | Yes | 2018-04-30 |
00603-5893 | Temazepam | Qualitest Pharmaceuticals | Yes | 2017-10-31 |
00603-5894 | Temazepam | Qualitest Pharmaceuticals | Yes | 2018-03-31 |
00603-7831 | Testosterone | Par Pharmaceutical, Inc. | Yes | 2024-02-28 |
00603-6134 | Torsemide | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6135 | Torsemide | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6136 | Torsemide | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6137 | Torsemide | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6160 | Trazodone Hydrochloride | Par Pharmaceutical | Yes | 2021-06-30 |
00603-6161 | Trazodone Hydrochloride | Par Pharmaceutical | Yes | 2021-06-30 |
00603-7663 | Tri-Previfem | Par Pharmaceutical | Yes | 2019-12-31 |
00603-1787 | Tri-Vit With Fluoride And Iron Drops | Par Pharmaceutical | Yes | 2021-03-31 |
00603-1785 | Tri-Vit with Fluoride Drops | Par Pharmaceutical | Yes | 2021-02-28 |
00603-1786 | Tri-Vit with Fluoride Drops | Par Pharmaceutical | Yes | 2021-03-31 |
00603-7861 | Triamcinolone Acetonide | Par Pharmaceutical | Yes | 2018-12-31 |
00603-7862 | Triamcinolone Acetonide | Par Pharmaceutical | Yes | 2019-07-31 |
00603-7864 | Triamcinolone Acetonide | Par Pharmaceutical | Yes | 2019-07-31 |
00603-6240 | Trihexyphenidyl Hydrochloride | Qualitest Pharmaceuticals | Yes | 2019-12-31 |
00603-6241 | Trihexyphenidyl Hydrochloride | Qualitest Pharmaceuticals | Yes | 2018-02-28 |
00603-0644 | Triple Antibiotic | Qualitest Pharmaceuticals | Yes | 2017-08-31 |
00603-0648 | Trixaicin | Qualitest Pharmaceuticals | Yes | 2018-02-28 |
00603-0649 | Trixaicin HP | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6330 | Valganciclovir | Par Pharmaceutical | Yes | No later than 2024-12-19 |
00603-1841 | Valproic Acid | Par Pharmaceutical | Yes | 2019-08-31 |
00603-6340 | Valsartan | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6341 | Valsartan | Qualitest Pharmaceuticals | Yes | 2017-08-31 |
00603-6342 | Valsartan | Qualitest Pharmaceuticals | Yes | 2017-08-31 |
00603-6343 | Valsartan | Qualitest Pharmaceuticals | Yes | 2017-04-30 |
00603-6345 | Valsartan and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6346 | Valsartan and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-08-31 |
00603-6347 | Valsartan and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-08-31 |
00603-6348 | Valsartan and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-05-31 |
00603-6349 | Valsartan and Hydrochlorothiazide | Qualitest Pharmaceuticals | Yes | 2017-05-31 |
00603-6149 | Venlafaxine | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6150 | Venlafaxine | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6151 | Venlafaxine | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6156 | Venlafaxine | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6157 | Venlafaxine | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-0410 | Vitamins A and D | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6468 | Zolpidem Tartrate | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
00603-6469 | Zolpidem Tartrate | Qualitest Pharmaceuticals | Yes | No later than 2017-04-03 |
10370-0102 | Bupropion Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2025-02-28 |
10370-0101 | Bupropion Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2025-05-31 |
10370-0159 | Bupropion Hydrochloride | Par Pharmaceuticals, Inc. | Yes | No later than 2014-12-22 |
10370-0160 | Bupropion Hydrochloride | Par Pharmaceuticals, Inc. | Yes | No later than 2014-12-22 |
10370-0161 | Bupropion Hydrochloride | Par Pharmaceuticals, Inc. | Yes | No later than 2014-12-22 |
10370-0204 | Bupropion Hydrochloride | Anchen Pharmaceuticals, Inc. | Yes | No later than 2017-12-29 |
10370-0107 | Ciprofloxacin Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
10370-0108 | Ciprofloxacin Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
10370-0302 | Clonidine Hydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
10370-0257 | Clonidine Hydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-04-30 |
10370-0170 | Darifenacin Hydrobromide Extended-Release | Par Pharmaceutical, Inc. | Yes | 2021-02-28 |
10370-0171 | Darifenacin Hydrobromide Extended-Release | Par Pharmaceutical, Inc. | Yes | 2021-02-28 |
10370-0832 | Diltiazem Hydrochloride Extended-Release | Endo USA, Inc. | No | |
10370-0831 | Diltiazem Hydrochloride Extended-Release | Endo USA, Inc. | No | |
10370-0830 | Diltiazem Hydrochloride Extended-Release | Endo USA, Inc. | No | |
10370-0829 | Diltiazem Hydrochloride Extended-Release | Endo USA, Inc. | No | |
10370-0510 | Divalproex Sodium Extended Release | Par Pharmaceutical, Inc. | Yes | 2021-06-30 |
10370-0511 | Divalproex Sodium Extended Release | Par Pharmaceutical, Inc. | Yes | 2021-01-31 |
10370-0280 | Dutasteride and Tamsulosin Hydrochloride | Endo USA, Inc. | No | |
10370-0209 | Fenofibric Acid Delayed-Release | Par Pharmaceutical, Inc. | Yes | 2021-02-28 |
10370-0210 | Fenofibric Acid Delayed-Release | Par Pharmaceutical, Inc. | Yes | 2021-07-31 |
10370-0176 | Fluvoxamine Maleate | Endo USA, Inc. | No | |
10370-0175 | Fluvoxamine Maleate | Endo USA, Inc. | No | |
10370-0746 | Glipizide | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
10370-0745 | Glipizide | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
10370-0191 | Glipizide ER | Par Pharmaceuticals, Inc. | Yes | 2019-01-31 |
10370-0190 | Glipizide ER | Par Pharmaceuticals, Inc. | Yes | 2019-01-31 |
10370-0533 | Guanfacine Extended-Release | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
10370-0534 | Guanfacine Extended-Release | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
10370-0536 | Guanfacine Extended-Release | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
10370-0538 | Guanfacine Extended-Release | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
10370-0214 | levetiracetam extended-release | Par Pharmaceutical, Inc. | Yes | No later than 2022-09-29 |
10370-0195 | levetiracetam extended-release | Par Pharmaceutical, Inc. | Yes | No later than 2022-09-29 |
10370-0266 | Lubiprostone | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
10370-0267 | Lubiprostone | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
10370-0347 | Memantine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
10370-0349 | Memantine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
10370-0348 | Memantine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
10370-0346 | Memantine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
10370-0679 | Nifedipine | Par Pharmaceutical, Inc. | Yes | 2019-11-30 |
10370-0678 | Nifedipine | Par Pharmaceutical, Inc. | Yes | 2019-11-30 |
10370-0677 | Nifedipine | Par Pharmaceutical, Inc. | Yes | 2019-11-30 |
10370-0390 | Nifedipine Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
10370-0391 | Nifedipine Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
10370-0392 | Nifedipine Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
10370-0219 | Potassium Chloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2019-09-30 |
10370-0220 | Potassium Chloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2020-01-31 |
10370-0305 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-07-31 |
10370-0251 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2022-10-31 |
10370-0252 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2022-07-31 |
10370-0253 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-09-30 |
10370-0254 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-01-31 |
10370-0255 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
10370-0306 | Pramipexole Dihydrochloride Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-01-31 |
10370-0169 | Tamsulosin Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2021-12-22 |
10370-0368 | Topiramate | Endo USA, Inc. | No | |
10370-0367 | Topiramate | Endo USA, Inc. | No | |
10370-0366 | Topiramate | Endo USA, Inc. | No | |
10370-0365 | Topiramate | Endo USA, Inc. | No | |
10370-0223 | Tramadol Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-01-31 |
10370-0222 | Tramadol Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-01-31 |
10370-0221 | Tramadol Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-01-31 |
10370-0268 | Tretinoin | Endo USA, Inc. | No | |
10370-0117 | Zolpidem Tartrate Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-06-30 |
10370-0116 | Zolpidem Tartrate Extended-Release | Par Pharmaceutical, Inc. | Yes | 2023-07-31 |
42023-0101 | Adrenalin | JHP Pharmaceuticals LLC | Yes | No later than 2013-12-31 |
42023-0168 | Adrenalin | Endo USA, Inc. | No | |
42023-0159 | Adrenalin | ENDO USA, Inc. | No | |
42023-0122 | Adrenalin | JHP Pharmaceuticals LLC | Yes | No later than 2013-12-31 |
42023-0315 | Adrenalin (epinephrine in sodium chloride) | Endo USA, Inc. | No | |
42023-0104 | Aplisol | ENDO USA, Inc. | No | |
42023-0182 | Argatroban | Endo USA, Inc. | No | |
42023-0622 | Bivalirudin | Endo USA, Inc. | No | |
42023-0105 | Brevital Sodium | Endo USA, Inc. | No | |
42023-0106 | Brevital Sodium | Par Pharmaceutical, Inc. | Yes | 2021-01-31 |
42023-0148 | Brevital Sodium | JHP Pharmaceuticals LLC | Yes | No later than 2014-12-22 |
42023-0179 | Buprenorphine Hydrochloride | ENDO USA, Inc. | No | |
42023-0205 | Calcitonin Salmon | ENDO USA, Inc. | No | |
42023-0131 | Colistimethate | Par Pharmaceutical, Inc. | Yes | No later than 2023-08-03 |
42023-0107 | Coly-Mycin M | Endo USA, Inc. | No | |
42023-0108 | Coly-Mycin S | Par Pharmaceutical, Inc. | Yes | 2017-06-18 |
42023-0196 | Corphedra | Par Pharmaceutical, Inc. | Yes | No later than 2024-12-19 |
42023-0233 | Corphedra | Par Pharmaceutical, Inc. | Yes | No later than 2024-12-19 |
42023-0109 | Cortisporin-TC | Par Pharmaceutical, Inc. | Yes | No later than 2019-03-18 |
42023-0123 | Dantrium | ENDO USA, Inc. | No | |
42023-0124 | Dantrium | Endo USA, Inc. | No | |
42023-0125 | Dantrium | Par Pharmaceutical, Inc. | Yes | 2022-02-28 |
42023-0126 | Dantrium | Par Pharmaceutical Inc. | Yes | No later than 2017-06-30 |
42023-0145 | dantrolene sodium | JHP Pharmaceuticals, LLC | Yes | No later than 2017-12-29 |
42023-0144 | dantrolene sodium | Par Pharmaceutical, Inc. | Yes | 2020-05-31 |
42023-0112 | Delestrogen | ENDO USA, Inc. | Yes | 2024-09-30 |
42023-0111 | Delestrogen | ENDO USA, Inc. | No | |
42023-0110 | Delestrogen | ENDO USA, Inc. | No | |
42023-0187 | Dexmedetomidine Hydrochloride | ENDO USA, Inc. | No | |
42023-0186 | Dexmedetomidine Hydrochloride | ENDO USA, Inc. | No | |
42023-0146 | Dexmedetomidine Hydrochloride | ENDO USA, Inc. | No | |
42023-0244 | DOXYCYCLINE | Endo USA, Inc. | No | |
42023-0253 | EPHEDRINE SULFATE | Par Pharmaceutical, Inc. | Yes | No later than 2024-06-26 |
42023-0243 | EPHEDRINE SULFATE | ENDO USA, Inc. | No | |
42023-0216 | Ephedrine Sulfate | Endo USA, Inc. | No | |
42023-0221 | ERTAPENEM | ENDO USA, Inc. | No | |
42023-0134 | Estradiol Valerate | JHP Pharmaceuticals, LLC | Yes | No later than 2017-06-30 |
42023-0135 | Estradiol Valerate | JHP Pharmaceuticals, LLC | Yes | No later than 2017-06-30 |
42023-0136 | Estradiol Valerate | JHP Pharmaceuticals, LLC | Yes | No later than 2017-06-30 |
42023-0157 | ETHACRYNATE SODIUM | Endo USA, Inc. | No | |
42023-0170 | Etomidate | Par Pharmaceutical, Inc. | Yes | No later than 2015-09-28 |
42023-0169 | Etomidate | Par Pharmaceutical, Inc. | Yes | No later than 2015-09-28 |
42023-0129 | Fluphenazine Decanoate | Endo USA, Inc. | No | |
42023-0173 | Ganciclovir | Endo USA, Inc. | No | |
42023-0115 | Ketalar | Endo USA, Inc. | No | |
42023-0114 | Ketalar | Endo USA, Inc. | No | |
42023-0113 | Ketalar | Endo USA, Inc. | No | |
42023-0137 | ketamine hydrochloride | Par Pharmaceutical Inc. | Yes | 2018-05-06 |
42023-0138 | ketamine hydrochloride | Par Pharmaceutical Inc. | Yes | 2018-04-29 |
42023-0139 | ketamine hydrochloride | Par Pharmaceutical Inc. | Yes | 2018-05-12 |
42023-0161 | Levothyroxine Sodium | Par Pharmaceutical Companies, Inc. | Yes | No later than 2019-12-28 |
42023-0203 | Levothyroxine Sodium | Par Pharmaceutical Inc. | No | |
42023-0202 | Levothyroxine Sodium | Par Pharmaceutical Inc. | No | |
42023-0201 | Levothyroxine Sodium | Par Pharmaceutical Inc. | No | |
42023-0149 | Melphalan Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2020-04-01 |
42023-0191 | Meropenem | Par Pharmaceutical, Inc. | Yes | 2018-09-30 |
42023-0192 | Meropenem | Par Pharmaceutical, Inc. | Yes | 2018-05-31 |
42023-0239 | METHYLPREDNISOLONE ACETATE | Endo USA, Inc. | No | |
42023-0238 | METHYLPREDNISOLONE ACETATE | Endo USA, Inc. | No | |
42023-0240 | Methylprednisolone Acetate | Endo USA, Inc. | No | |
42023-0230 | Micafungin | Endo USA, Inc. | No | |
42023-0229 | Micafungin | Endo USA, Inc. | No | |
42023-0172 | Mycophenolate Mofetil | Endo USA, Inc. | No | |
42023-0224 | Naloxone Hydrochloride | Endo USA, Inc. | No | |
42023-0188 | NEOSTIGMINE METHYLSULFATE | Endo USA, Inc. | No | |
42023-0189 | NEOSTIGMINE METHYLSULFATE | Endo USA, Inc. | No | |
42023-0247 | NOREPINEPHRINE BITARTRATE | Par Pharmaceutical, Inc. | Yes | No later than 2024-03-26 |
42023-0245 | NOREPINEPHRINE BITARTRATE | Par Pharmaceutical, Inc. | Yes | No later than 2024-03-26 |
42023-0246 | NOREPINEPHRINE BITARTRATE | Par Pharmaceutical, Inc. | Yes | No later than 2024-03-26 |
42023-0141 | Oxytocin | JHP Pharmaceuticals, LLC | Yes | No later than 2017-06-30 |
42023-0140 | Oxytocin | JHP Pharmaceuticals, LLC | Yes | No later than 2017-06-30 |
42023-0215 | Phenylephrine hydrochloride | Endo USA, Inc. | No | |
42023-0213 | Phenylephrine hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-01-31 |
42023-0214 | Phenylephrine hydrochloride | Endo USA, Inc. | No | |
42023-0130 | Pitocin | Endo USA, Inc. | No | |
42023-0116 | Pitocin | Endo USA, Inc. | No | |
42023-0117 | Pitressin | Par Pharmaceutical, Inc. | Yes | 2016-06-30 |
42023-0195 | Posaconazole | ENDO USA, Inc. | No | |
42023-0269 | PREVDUO | Endo USA | No | |
42023-0121 | sumatriptan succinate | JHP Pharmaceuticals LLC | Yes | No later than 2019-12-28 |
42023-0119 | Tigan | Endo USA, Inc. | No | |
42023-0118 | Tigan | Par Pharmaceutical, Inc. | Yes | 2022-03-31 |
42023-0208 | Treprostinil | Endo USA, Inc. | Yes | No later than 2025-03-24 |
42023-0206 | Treprostinil | Endo USA, Inc. | Yes | 2025-03-31 |
42023-0207 | Treprostinil | Endo USA, Inc. | Yes | No later than 2025-03-24 |
42023-0209 | Treprostinil | Endo USA, Inc. | Yes | No later than 2025-03-24 |
42023-0142 | Trimethobenzamide Hydrochloride | JHP Pharmaceuticals, LLC | Yes | No later than 2015-09-28 |
42023-0143 | Trimethobenzamide Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2016-12-31 |
42023-0120 | Triostat | Par Pharmaceutical, Inc. | Yes | No later than 2023-03-29 |
42023-0190 | Vasostrict | ENDO USA, Inc. | No | |
42023-0237 | Vasostrict | ENDO USA, Inc. | No | |
42023-0220 | Vasostrict | Par Pharmaceutical, Inc. | Yes | No later than 2023-12-19 |
42023-0164 | Vasostrict | ENDO USA, Inc. | No | |
42023-0219 | Vasostrict | ENDO USA, Inc. | No | |
42023-0167 | Zoledronic Acid | JHP Pharmaceuticals, LLC. | Yes | No later than 2019-12-28 |
42023-0163 | Zoledronic Acid | Par Pharmaceutical Companies, Inc. | Yes | No later than 2019-12-28 |
42023-0151 | Zoledronic Acid | Par Pharmaceutical Companies, Inc. | Yes | No later than 2019-12-28 |
49884-0010 | ACCOLATE | Par Pharmaceutical Inc. | Yes | No later than 2019-06-25 |
49884-0011 | ACCOLATE | Par Pharmaceutical Inc. | Yes | No later than 2019-06-25 |
49884-0589 | Accolate | Par Pharmaceutical, Inc. | Yes | 2024-04-30 |
49884-0590 | Accolate | Par Pharmaceutical, Inc. | Yes | 2023-11-30 |
49884-0424 | ALISKIREN | Endo USA, Inc. | No | |
49884-0425 | ALISKIREN | Endo USA, Inc. | No | |
49884-0819 | ALOSETRON HYDROCHLORIDE | Par Pharmaceutical, Inc. | Yes | No later than 2023-09-14 |
49884-0820 | ALOSETRON HYDROCHLORIDE | Par Pharmaceutical, Inc. | Yes | No later than 2023-09-14 |
49884-0110 | Alprazolam | Endo USA, Inc. | No | |
49884-0111 | Alprazolam | Endo USA, Inc. | No | |
49884-0213 | Alprazolam | Endo USA, Inc. | No | |
49884-0214 | Alprazolam | Endo USA, Inc. | No | |
49884-0353 | Ambrisentan | Par Pharmaceutical, Inc. | Yes | 2023-01-31 |
49884-0354 | Ambrisentan | Par Pharmaceutical, Inc. | Yes | 2022-12-31 |
49884-0117 | Amiloride Hydrochloride | Endo USA, Inc. | No | |
49884-0574 | Amlodipine and Valsartan | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0575 | Amlodipine and Valsartan | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0576 | Amlodipine and Valsartan | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0577 | Amlodipine and Valsartan | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0929 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0930 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0931 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0932 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0952 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0953 | Amlodipine besylate and benazepril hydrochloride | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0172 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | Par Pharmaceutical, Inc. | Yes | 2022-05-31 |
49884-0173 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | Par Pharmaceutical, Inc. | Yes | 2022-05-31 |
49884-0174 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | Par Pharmaceutical, Inc. | Yes | 2022-05-31 |
49884-0175 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | Par Pharmaceutical, Inc. | Yes | 2022-05-31 |
49884-0185 | AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE | Par Pharmaceutical, Inc. | Yes | 2022-05-31 |
49884-0007 | Aspirin and Extended - Release Dipyridamole Capsules, 25 mg / 200 mg | Endo USA, Inc. | No | |
49884-0367 | Balsalazide Disodium | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
49884-0151 | Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride | Endo USA, Inc. | No | |
49884-0058 | Bosentan | Par Pharmaceutical, Inc. | Yes | 2023-08-31 |
49884-0059 | Bosentan | Par Pharmaceutical, Inc. | Yes | 2023-11-30 |
49884-0157 | Budesonide | Par Pharmaceutical Inc. | Yes | No later than 2017-04-03 |
49884-0501 | Budesonide | Par Pharmaceutical Inc. | Yes | No later than 2018-10-01 |
49884-0725 | Buspirone Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-08-31 |
49884-0673 | Cabergoline | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0161 | CALCITONIN SALMON | Endo USA, Inc. | No | |
49884-0658 | Candesartan cilexetil | Par Pharmaceutical Inc. | Yes | 2025-12-31 |
49884-0659 | Candesartan cilexetil | Par Pharmaceutical Inc. | Yes | 2026-04-30 |
49884-0660 | Candesartan cilexetil | Par Pharmaceutical Inc. | Yes | 2026-01-31 |
49884-0661 | Candesartan cilexetil | Par Pharmaceutical Inc. | Yes | 2025-08-31 |
49884-0662 | Candesartan Cilexetil-Hydrochlorothiazide | Par Pharmaceutical Inc. | Yes | No later than 2017-06-30 |
49884-0663 | Candesartan Cilexetil-Hydrochlorothiazide | Par Pharmaceutical Inc. | Yes | No later than 2017-06-30 |
49884-0664 | Candesartan Cilexetil-Hydrochlorothiazide | Par Pharmaceutical Inc. | Yes | No later than 2017-06-30 |
49884-0265 | Chlordiazepoxide and Amitriptyline HCl | Par Pharmaceutical Inc | Yes | No later than 2019-03-18 |
49884-0266 | Chlordiazepoxide and Amitriptyline HCl | Par Pharmaceutical Inc | Yes | No later than 2019-03-18 |
49884-0465 | Cholestyramine | Endo USA, Inc. | No | |
49884-0466 | Cholestyramine | Endo USA, Inc. | No | |
49884-0238 | CLARITHROMYCIN | Par Pharmaceutical, Inc. | Yes | No later than 2019-06-25 |
49884-0701 | Clomiphene Citrate | Par Pharmaceutical, Inc. | Yes | 2025-02-28 |
49884-0306 | Clonazepam | Endo USA, Inc. | No | |
49884-0307 | Clonazepam | Endo USA, Inc. | No | |
49884-0308 | Clonazepam | Endo USA, Inc. | No | |
49884-0309 | Clonazepam | Endo USA, Inc. | No | |
49884-0310 | Clonazepam | Endo USA, Inc. | No | |
49884-0774 | Clonidine | Par Pharmaceutical, Inc. | Yes | No later than 2014-12-22 |
49884-0775 | Clonidine | Par Pharmaceutical, Inc. | Yes | No later than 2014-12-22 |
49884-0776 | Clonidine | Par Pharmaceutical, Inc. | Yes | No later than 2014-12-22 |
49884-0171 | Colchicine | Endo USA, Inc. | No | |
49884-0043 | Cyproheptadine Hydrochloride | Par Pharmaceutical Inc. | Yes | No later than 2014-12-22 |
49884-0362 | dantrolene sodium | Endo USA, Inc. | No | |
49884-0363 | dantrolene sodium | Endo USA, Inc. | No | |
49884-0364 | dantrolene sodium | Endo USA, Inc. | No | |
49884-0084 | Dexamethasone | Par Pharmaceutical Inc. | Yes | 2019-12-31 |
49884-0085 | Dexamethasone | Par Pharmaceutical Inc. | Yes | 2019-08-31 |
49884-0086 | Dexamethasone | Par Pharmaceutical Inc. | Yes | 2020-02-29 |
49884-0087 | Dexamethasone | Par Pharmaceutical Inc. | Yes | 2020-05-31 |
49884-0129 | Dexamethasone | Par Pharmaceutical Inc. | Yes | No later than 2017-06-30 |
49884-0373 | Dexamethasone | Par Pharmaceutical Inc. | Yes | 2019-12-31 |
49884-0147 | Dexlansoprazole | ENDO USA, Inc. | No | |
49884-0148 | Dexlansoprazole | ENDO USA, Inc. | No | |
49884-0048 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | No | |
49884-0049 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | No | |
49884-0090 | Dexmethylphenidate Hydrochloride | ENDO USA, Inc. | Yes | No later than 2025-03-24 |
49884-0248 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | No | |
49884-0333 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | No | |
49884-0339 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | No | |
49884-0539 | Dexmethylphenidate Hydrochloride | ENDO USA, Inc. | Yes | No later than 2025-03-24 |
49884-0546 | Dexmethylphenidate Hydrochloride | Endo USA, Inc. | No | |
49884-0428 | Dexmethylphenidate Hydrochloride Extended-Release | Par Pharmaceuticals, Inc. | No | |
49884-0430 | Dexmethylphenidate Hydrochloride Extended-Release | Par Pharmaceuticals, Inc. | No | |
49884-0839 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | Yes | 2023-11-30 |
49884-0840 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | Yes | 2023-11-30 |
49884-0841 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | Yes | 2023-11-30 |
49884-0842 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | Yes | 2023-11-30 |
49884-0843 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | Yes | 2023-11-30 |
49884-0844 | Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER | Par Pharmaceutical, Inc. | Yes | 2023-11-30 |
49884-0905 | Diclofenac Potassium | Endo USA, Inc. | No | |
49884-0935 | Diclofenac Sodium | Par Pharmaceutical Inc | Yes | No later than 2021-09-22 |
49884-0494 | DIGOXIN | Par Pharmaceutical Inc. | Yes | 2020-08-31 |
49884-0514 | DIGOXIN | Par Pharmaceutical Inc. | Yes | 2021-02-28 |
49884-0829 | Diltiazem Hydrochloride Extended Release | Par Pharmaceutical, Inc. | Yes | No later than 2019-03-18 |
49884-0830 | Diltiazem Hydrochloride Extended Release | Par Pharmaceutical, Inc. | Yes | No later than 2019-03-18 |
49884-0831 | Diltiazem Hydrochloride Extended Release | Par Pharmaceutical, Inc. | Yes | No later than 2019-03-18 |
49884-0832 | Diltiazem Hydrochloride Extended Release | Par Pharmaceutical, Inc. | Yes | No later than 2019-03-18 |
49884-0771 | Diphenoxylate Hydrochloride and Atropine Sulfate | Par Pharmaceutical, Inc. | Yes | No later than 2019-12-28 |
49884-0232 | Donepezil hydrochloride | Par Pharmaceutical, Inc. | Yes | 2020-07-31 |
49884-0217 | Doxepin Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-07-31 |
49884-0218 | Doxepin Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-07-31 |
49884-0219 | Doxepin Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-07-31 |
49884-0220 | Doxepin Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2022-12-30 |
49884-0221 | Doxepin Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2023-08-31 |
49884-0222 | Doxepin Hydrochloride | Endo USA, Inc. | No | |
49884-0091 | Doxycycline | Par Pharmaceutical, Inc. | Yes | 2020-03-31 |
49884-0092 | Doxycycline | Par Pharmaceutical, Inc. | Yes | 2020-03-31 |
49884-0093 | Doxycycline | Par Pharmaceutical, Inc. | Yes | 2020-08-31 |
49884-0236 | Doxycycline | Par Pharmaceutical, Inc. | Yes | 2020-06-30 |
49884-0305 | Doxycycline | Par Pharmaceutical, Inc. | Yes | 2024-02-28 |
49884-0726 | Doxycycline | Par Pharmaceutical, Inc. | Yes | 2024-11-30 |
49884-0727 | Doxycycline | Par Pharmaceutical, Inc. | Yes | 2024-12-31 |
49884-0186 | Doxylamine Succinate and Pyridoxine Hydrochloride | Endo USA, Inc. | No | |
49884-0867 | Dronabinol | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0868 | Dronabinol | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0869 | Dronabinol | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0096 | DYNACIN | Par Pharmaceutical, Inc. | Yes | No later than 2019-12-28 |
49884-0097 | DYNACIN | Par Pharmaceutical, Inc. | Yes | No later than 2019-12-28 |
49884-0098 | DYNACIN | Par Pharmaceutical, Inc. | Yes | No later than 2019-12-28 |
49884-0104 | Entecavir | Par Pharmaceutical Inc. | Yes | 2017-08-31 |
49884-0105 | Entecavir | Par Pharmaceutical Inc. | Yes | 2017-08-31 |
49884-0547 | Entecavir | Par Pharmaceutical, Inc. | Yes | No later than 2020-04-01 |
49884-0548 | Entecavir | Par Pharmaceutical, Inc. | Yes | No later than 2020-04-01 |
49884-0112 | Estazolam | Par Pharmaceutical Inc. | Yes | No later than 2013-09-27 |
49884-0343 | Estazolam | Par Pharmaceutical Inc. | Yes | No later than 2013-09-27 |
49884-0276 | Ethacrynic Acid | Par Pharmaceutical, Inc. | Yes | 2022-04-30 |
49884-0119 | Everolimus | ENDO USA, Inc. | No | |
49884-0125 | Everolimus | ENDO USA, Inc. | No | |
49884-0127 | Everolimus | ENDO USA, Inc. | No | |
49884-0128 | Everolimus | ENDO USA, Inc. | No | |
49884-0158 | Everolimus | ENDO USA, Inc. | No | |
49884-0159 | Everolimus | ENDO USA, Inc. | No | |
49884-0160 | Everolimus | ENDO USA, Inc. | No | |
49884-0283 | Everolimus | ENDO USA, Inc. | No | |
49884-0228 | Ezetimibe | Par Pharmaceutical Inc | Yes | 2020-03-31 |
49884-0761 | Fentanyl | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0762 | Fentanyl | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0763 | Fentanyl | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0764 | Fentanyl | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0459 | Fentanyl Citrate | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
49884-0460 | Fentanyl Citrate | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
49884-0461 | Fentanyl Citrate | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
49884-0462 | Fentanyl Citrate | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
49884-0463 | Fentanyl Citrate | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
49884-0464 | Fentanyl Citrate | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
49884-0468 | Fluoxetine | Endo USA, Inc. | No | |
49884-0872 | FLUOXETINE | Par Pharmaceutical, Inc. | Yes | 2021-10-31 |
49884-0335 | fluoxetine hydrochloride | Endo USA, Inc. | No | |
49884-0336 | fluoxetine hydrochloride | Endo USA, Inc. | No | |
49884-0734 | Fluoxetine Hydrochloride | Par Pharmaceutical, Inc | Yes | 2016-11-30 |
49884-0735 | Fluoxetine Hydrochloride | Par Pharmaceutical, Inc | Yes | 2016-12-31 |
49884-0753 | Flutamide | Par Pharmaceutical, Inc. | Yes | 2023-08-31 |
49884-0745 | Glipizide | Par Pharmaceutical, Inc. | Yes | No later than 2019-03-18 |
49884-0746 | Glipizide | Par Pharmaceutical, Inc. | Yes | No later than 2019-03-18 |
49884-0042 | Glycopyrrolate | Endo USA, Inc. | No | |
49884-0065 | Glycopyrrolate | Endo USA, Inc. | No | |
49884-0066 | Glycopyrrolate | Endo USA, Inc. | No | |
49884-0027 | Hydralazine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2018-04-30 |
49884-0028 | Hydralazine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2018-04-30 |
49884-0029 | Hydralazine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2018-04-30 |
49884-0121 | Hydralazine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2018-04-30 |
49884-0235 | Hydrocodone Polistirex and Chlorpheniramine Polisitrex | Par Pharmaceutical Companies Inc | Yes | No later than 2017-12-29 |
49884-0724 | Hydroxyurea | Endo USA, Inc. | No | |
49884-0366 | Ibuprofen and famotidine | ENDO USA, Inc. | No | |
49884-0054 | Imipramine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2024-01-31 |
49884-0055 | Imipramine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2024-08-31 |
49884-0056 | Imipramine Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2024-01-31 |
49884-0009 | Isosorbide Dinitrate | Endo USA, Inc. | No | |
49884-0020 | Isosorbide Dinitrate | Endo USA, Inc. | No | |
49884-0021 | Isosorbide Dinitrate | Endo USA, Inc. | No | |
49884-0022 | Isosorbide Dinitrate | Endo USA, Inc. | No | |
49884-0556 | Isosorbide Dinitrate | Endo USA, Inc. | No | |
49884-0239 | Itraconazole | Par Pharmaceutical, Inc. | Yes | 2025-07-31 |
49884-0374 | KHEDEZLA Extended-release | Par Pharmaceutical Inc. | Yes | No later than 2017-04-03 |
49884-0375 | KHEDEZLA Extended-release | Par Pharmaceutical Inc. | Yes | No later than 2017-04-03 |
49884-0122 | Labetalol HCL | Endo USA, Inc. | No | |
49884-0123 | Labetalol HCL | Endo USA, Inc. | No | |
49884-0124 | Labetalol HCL | Endo USA, Inc. | No | |
49884-0484 | Lamotrigine | Endo USA, Inc. | No | |
49884-0485 | Lamotrigine | Endo USA, Inc. | No | |
49884-0486 | Lamotrigine | Endo USA, Inc. | No | |
49884-0487 | Lamotrigine | Endo USA, Inc. | No | |
49884-0880 | Lamotrigine | Endo USA, Inc. | No | |
49884-0881 | Lamotrigine | Endo USA, Inc. | No | |
49884-0882 | Lamotrigine | Endo USA, Inc. | No | |
49884-0561 | Lamotrigine Extended Release | Endo USA, Inc. | No | |
49884-0562 | Lamotrigine Extended Release | Endo USA, Inc. | No | |
49884-0563 | Lamotrigine Extended Release | Endo USA, Inc. | No | |
49884-0564 | Lamotrigine Extended Release | Endo USA, Inc. | No | |
49884-0604 | Lamotrigine Extended Release | Endo USA, Inc. | No | |
49884-0605 | Lamotrigine Extended Release | Endo USA, Inc. | No | |
49884-0204 | Levetiracetam | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0205 | Levetiracetam | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0902 | Mafenide acetate | Par Pharmaceutical, Inc. | Yes | 2025-05-31 |
49884-0034 | Meclizine Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2021-12-22 |
49884-0035 | Meclizine Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2021-12-22 |
49884-0949 | Megace ES | Par Pharmaceutical, Inc | Yes | No later than 2019-10-01 |
49884-0230 | Megestrol Acetate | Par Pharmaceutical, Inc. | Yes | 2023-05-31 |
49884-0289 | Megestrol Acetate | Par Pharmaceutical, Inc. | Yes | 2024-08-31 |
49884-0290 | Megestrol Acetate | Par Pharmaceutical, Inc. | Yes | 2024-12-31 |
49884-0907 | Megestrol Acetate | Endo USA, Inc. | Yes | 2024-12-31 |
49884-0922 | mercaptopurine | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0258 | Metaproterenol Sulfate | Par Pharmaceutical, Inc. | Yes | 2019-09-30 |
49884-0259 | Metaproterenol Sulfate | Par Pharmaceutical, Inc. | Yes | 2019-09-30 |
49884-0640 | Methimazole | Par Pharmaceutical, Inc. | Yes | 2024-10-31 |
49884-0641 | Methimazole | Par Pharmaceutical, Inc. | Yes | 2024-10-31 |
49884-0685 | Metoclopramide | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
49884-0689 | Metoclopramide | Par Pharmaceutical, Inc. | Yes | 2023-10-31 |
49884-0404 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | Yes | 2019-08-31 |
49884-0405 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | Yes | 2019-10-31 |
49884-0406 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | Yes | 2019-09-30 |
49884-0407 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | Yes | 2016-11-30 |
49884-0825 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | Yes | 2021-05-31 |
49884-0826 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | Yes | 2021-05-31 |
49884-0827 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | Yes | 2021-05-31 |
49884-0828 | METOPROLOL SUCCINATE | Par Pharmaceutical Inc. | Yes | 2021-04-30 |
49884-0814 | Midodrine Hydrochloride | Endo USA, Inc. | No | |
49884-0849 | Midodrine Hydrochloride | Endo USA, Inc. | No | |
49884-0874 | Midodrine Hydrochloride | Endo USA, Inc. | No | |
49884-0511 | Minocycline | Par Pharmaceutical, Inc. | Yes | 2024-03-31 |
49884-0512 | Minocycline | Par Pharmaceutical, Inc. | Yes | 2023-01-31 |
49884-0513 | Minocycline | Par Pharmaceutical, Inc. | Yes | 2024-04-30 |
49884-0256 | Minoxidil | Endo USA, Inc. | No | |
49884-0257 | Minoxidil | Endo USA, Inc. | No | |
49884-0534 | Modafinil | Par Pharmaceutical Inc. | Yes | 2020-12-31 |
49884-0535 | Modafinil | Par Pharmaceutical Inc. | Yes | 2020-08-31 |
49884-0665 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0666 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0667 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0668 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0669 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0670 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | No later than 2019-12-28 |
49884-0833 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | 2018-11-30 |
49884-0834 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | 2019-02-28 |
49884-0835 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | 2018-07-31 |
49884-0836 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | 2019-02-28 |
49884-0837 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | 2018-11-30 |
49884-0838 | Morphine Sulfate | Par Pharmaceutical Inc. | Yes | 2019-02-28 |
49884-0195 | Nabumetone | Par Pharmaceutical Inc. | Yes | No later than 2015-03-31 |
49884-0196 | Nabumetone | Par Pharmaceutical Inc. | Yes | No later than 2015-03-31 |
49884-0649 | Nabumetone | Par Pharmaceutical Inc | Yes | No later than 2019-12-28 |
49884-0650 | Nabumetone | Par Pharmaceutical Inc | Yes | No later than 2019-12-28 |
49884-0270 | Nascobal | ENDO USA, Inc. | Yes | 2026-12-31 |
49884-0984 | Nateglinide | Par Pharmaceutical, Inc. | Yes | 2024-09-30 |
49884-0985 | Nateglinide | Par Pharmaceutical, Inc. | Yes | 2023-11-30 |
49884-0677 | Nifedipine Extended Release | Par Pharmaceutical, Inc. | Yes | No later than 2019-12-28 |
49884-0678 | Nifedipine Extended Release | Par Pharmaceutical, Inc. | Yes | No later than 2019-12-28 |
49884-0679 | Nifedipine Extended Release | Par Pharmaceutical, Inc. | Yes | No later than 2019-12-28 |
49884-0320 | Olanzapine | Par Pharmaceutical, Inc. | Yes | 2024-09-24 |
49884-0321 | Olanzapine | Par Pharmaceutical, Inc. | Yes | 2024-07-31 |
49884-0322 | Olanzapine | Par Pharmaceutical, Inc. | Yes | 2024-09-24 |
49884-0323 | Olanzapine | Par Pharmaceutical, Inc. | Yes | 2024-09-24 |
49884-0250 | Olanzapine and Fluoxetine | Endo USA, Inc. | No | |
49884-0251 | Olanzapine and Fluoxetine | Endo USA, Inc. | No | |
49884-0252 | Olanzapine and Fluoxetine | Endo USA, Inc. | No | |
49884-0253 | Olanzapine and Fluoxetine | Endo USA, Inc. | No | |
49884-0277 | Olanzapine and Fluoxetine | Endo USA, Inc. | No | |
49884-0786 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Endo USA, Inc. | No | |
49884-0787 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Endo USA, Inc. | No | |
49884-0788 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Endo USA, Inc. | No | |
49884-0789 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Endo USA, Inc. | No | |
49884-0790 | olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide | Endo USA, Inc. | No | |
49884-0019 | Omega-3-Acid Ethyl Esters | Par Pharmaceutical, Inc. | Yes | 2021-03-31 |
49884-0397 | Omeprazole and Sodium Bicarbonate | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
49884-0455 | Omeprazole and Sodium Bicarbonate | Par Pharmaceutical Inc. | Yes | No later than 2019-03-18 |
49884-0268 | Omeprazole/Sodium Bicarbonate | Par Pharmaceutical, Inc. | Yes | 2023-12-31 |
49884-0269 | Omeprazole/Sodium Bicarbonate | Par Pharmaceutical, Inc. | Yes | 2024-11-30 |
49884-0082 | ORAVIG | Par Pharmaceuticals Companies, Inc. | Yes | No later than 2013-06-28 |
49884-0301 | Oxandrolone | Par Pharmaceutical, Inc. | Yes | 2025-10-31 |
49884-0302 | Oxandrolone | Par Pharmaceutical, Inc. | Yes | 2025-10-31 |
49884-0136 | oxycodone hydrochloride | Par Pharmaceutical, Inc. | Yes | 2020-12-31 |
49884-0137 | oxycodone hydrochloride | Par Pharmaceutical, Inc. | Yes | 2020-12-31 |
49884-0138 | oxycodone hydrochloride | Par Pharmaceutical, Inc. | Yes | 2020-12-31 |
49884-0197 | oxycodone hydrochloride | Par Pharmaceutical, Inc. | Yes | 2020-12-31 |
49884-0146 | Penicillamine | Endo USA, Inc. | No | |
49884-0038 | Phenoxybenzamine Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2025-03-24 |
49884-0347 | Pimozide | Endo USA, Inc. | No | |
49884-0348 | Pimozide | Endo USA, Inc. | No | |
49884-0231 | PRAZIQUANTEL | Endo USA, Inc. | No | |
49884-0099 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2017-12-29 |
49884-0113 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2024-09-30 |
49884-0210 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2024-09-30 |
49884-0211 | Propafenone Hydrochloride | Par Pharmaceutical, Inc. | Yes | 2024-09-30 |
49884-0282 | Propranolol Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2014-12-22 |
49884-0328 | Propranolol Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2014-12-22 |
49884-0329 | Propranolol Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2014-12-22 |
49884-0330 | Propranolol Hydrochloride | Par Pharmaceutical, Inc. | Yes | No later than 2014-12-22 |
49884-0936 | QUESTRAN | Endo USA, Inc. | No | |
49884-0937 | QUESTRAN | Endo USA, Inc. | No | |
49884-0805 | Quetiapine Fumarate Extended Release | Par Pharmaceutical Inc. | Yes | 2019-10-31 |
49884-0806 | Quetiapine Fumarate Extended Release | Par Pharmaceutical Inc. | Yes | 2019-10-31 |
49884-0807 | Quetiapine Fumarate Extended Release | Par Pharmaceutical Inc. | Yes | 2019-09-30 |
49884-0808 | Quetiapine Fumarate Extended Release | Par Pharmaceutical Inc. | Yes | 2019-08-31 |
49884-0544 | Ranitidine | Par Pharmaceutical Inc | Yes | No later than 2014-12-22 |
49884-0545 | Ranitidine | Par Pharmaceutical Inc | Yes | No later than 2019-12-28 |
49884-0071 | RIBASPHERE RibaPak | PAR Pharmaceutical Companies, Inc. | Yes | No later than 2015-03-31 |
49884-0338 | RIBASPHERE RibaPak | PAR Pharmaceutical Companies, Inc. | Yes | No later than 2015-03-31 |
49884-0340 | RIBASPHERE RibaPak | PAR Pharmaceutical Companies, Inc. | Yes | No later than 2015-03-31 |
49884-0212 | Risperidone | ENDO USA, Inc. | No | |
49884-0311 | Risperidone | ENDO USA, Inc. | No | |
49884-0315 | Risperidone | ENDO USA, Inc. | No | |
49884-0401 | Risperidone | ENDO USA, Inc. | No | |
49884-0402 | Risperidone | ENDO USA, Inc. | No | |
49884-0403 | Risperidone | ENDO USA, Inc. | No | |
49884-0578 | Rizatriptan Benzoate | Par Pharmaceutical Inc. | Yes | No later than 2017-04-03 |
49884-0579 | Rizatriptan Benzoate | Par Pharmaceutical Inc. | Yes | No later than 2017-04-03 |
49884-0580 | Rizatriptan Benzoate | Par Pharmaceutical Inc. | Yes | 2018-04-30 |
49884-0581 | Rizatriptan Benzoate | Par Pharmaceutical Inc. | Yes | 2018-01-31 |
49884-0260 | Rosuvastatin Calcium | Par Pharmaceutical, Inc. | Yes | 2020-06-30 |
49884-0261 | Rosuvastatin Calcium | Par Pharmaceutical, Inc. | Yes | 2020-08-31 |
49884-0262 | Rosuvastatin Calcium | Par Pharmaceutical, Inc. | Yes | 2020-08-31 |
49884-0263 | Rosuvastatin Calcium | Par Pharmaceutical, Inc. | Yes | 2020-06-30 |
49884-0720 | sapropterin dihydrochloride | ENDO USA, Inc. | No | |
49884-0873 | SAPROPTERIN DIHYDROCHLORIDE | ENDO USA, Inc. | No | |
49884-0948 | SAPROPTERIN DIHYDROCHLORIDE | ENDO USA, Inc. | No | |
49884-0006 | Sodium Phenylbutyrate | ENDO USA, Inc. | No | |
49884-0170 | Sodium Phenylbutyrate | ENDO USA, Inc. | No | |
49884-0600 | SSD | Par Pharmaceutical Inc. | Yes | No later than 2014-12-22 |
49884-0601 | SSD | Par Pharmaceutical Inc. | Yes | No later than 2014-12-22 |
49884-0482 | SUMATRIPTAN SUCCINATE | Par Pharmaceutical Inc | Yes | 2013-10-05 |
49884-0483 | SUMATRIPTAN SUCCINATE | Par Pharmaceutical Inc | Yes | 2013-08-29 |
49884-0516 | Sumatriptan Succinate | Par Pharmaceutical, Inc. | Yes | No later than 2013-03-29 |
49884-0732 | SUMYCIN | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0733 | SUMYCIN | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0418 | Testosterone | Par Pharmaceutical, Inc. | Yes | 2024-02-28 |
49884-0510 | Testosterone | Par Pharmaceutical, Inc. | Yes | 2024-02-28 |
49884-0773 | TIZANIDINE | Par Pharmaceutical, Inc. | Yes | 2019-07-31 |
49884-0947 | TIZANIDINE | Par Pharmaceutical, Inc. | Yes | No later than 2022-06-28 |
49884-0611 | tizanidine hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-05-31 |
49884-0719 | tizanidine hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-05-31 |
49884-0765 | tizanidine hydrochloride | Par Pharmaceutical, Inc. | Yes | 2022-05-31 |
49884-0254 | Tolcapone | Par Pharmaceutical, Inc. | Yes | No later than 2021-12-22 |
49884-0768 | Tolvaptan | Endo USA, Inc. | No | |
49884-0770 | Tolvaptan | Endo USA, Inc. | No | |
49884-0106 | Torsemide | Par Pharmaceutical Inc | Yes | No later than 2017-04-03 |
49884-0107 | Torsemide | Par Pharmaceutical Inc | Yes | No later than 2017-04-03 |
49884-0108 | Torsemide | Par Pharmaceutical Inc | Yes | No later than 2017-04-03 |
49884-0109 | Torsemide | Par Pharmaceutical Inc | Yes | No later than 2017-04-03 |
49884-0821 | TRAMADOL HYDROCHLORIDE | Par Pharmaceutical, Inc. | Yes | 2018-10-31 |
49884-0822 | TRAMADOL HYDROCHLORIDE | Par Pharmaceutical, Inc. | Yes | 2019-03-31 |
49884-0823 | TRAMADOL HYDROCHLORIDE | Par Pharmaceutical, Inc. | Yes | 2019-02-28 |
49884-0946 | Tramadol hydrochloride and acetaminophen | Par Pharmaceutical, Inc. | Yes | 2022-01-31 |
49884-0032 | TRANYLCYPROMINE SULFATE | Par Pharmaceutical, Inc. | Yes | 2024-11-30 |
49884-0044 | Travoprost Ophthalmic Solution 0.004% | Par Pharmaceutical, Inc. | Yes | 2019-10-31 |
49884-0060 | Trientine Hydrochloride | Endo USA, Inc. | No | |
49884-0412 | Ursodiol | Endo USA, Inc. | No | |
49884-0413 | Ursodiol | Endo USA, Inc. | No | |
49884-0155 | Varenicline | ENDO USA, Inc. | No | |
49884-0156 | Varenicline | ENDO USA, Inc. | No | |
49884-0944 | Varenicline | ENDO USA, Inc. | No | |
49884-0358 | VIGABATRIN | ENDO USA, Inc. | No | |
49884-0303 | ZAFIRLUKAST | Par Pharmaceutical Inc. | Yes | 2017-08-31 |
49884-0304 | ZAFIRLUKAST | Par Pharmaceutical Inc. | Yes | 2018-02-28 |
49884-0549 | Zafirlukast | Par Pharmaceutical, Inc. | Yes | 2024-04-30 |
49884-0554 | Zafirlukast | Par Pharmaceutical, Inc. | Yes | 2024-09-30 |
49884-0723 | Zileuton | Par Pharmaceutical, Inc. | Yes | 2023-11-30 |
49884-0903 | Zolpidem tartrate | Par Pharmaceutical, Inc. | Yes | No later than 2024-12-19 |
49884-0904 | Zolpidem tartrate | Par Pharmaceutical, Inc. | Yes | No later than 2024-12-19 |
49884-0898 | Zolpidem tartrate sublingual | ENDO USA, Inc. | No | |
49884-0899 | Zolpidem tartrate sublingual | ENDO USA, Inc. | No | |
49884-0324 | Zuplenz | Par Pharmaceutical, Inc. | Yes | No later than 2012-12-29 |
49884-0325 | Zuplenz | Par Pharmaceutical, Inc. | Yes | No later than 2012-12-29 |
52244-0920 | Dilatrate SR | Endo Pharmaceuticals Inc. | Yes | 2021-08-31 |
52244-0010 | Edex | ENDO USA, Inc. | No | |
52244-0020 | Edex | ENDO USA, Inc. | No | |
52244-0040 | Edex | ENDO USA, Inc. | No | |
52244-0450 | Levatol | Actient Pharmaceuticals, LLC | Yes | No later than 2014-09-24 |
52244-0429 | Robaxin | Endo Pharmaceuticals, Inc. | Yes | No later than 2019-10-01 |
52244-0449 | Robaxin | Endo Pharmaceuticals Inc. | Yes | 2021-03-31 |
52244-0404 | SEMPREX D | Endo Pharmaceuticals Inc. | Yes | 2020-12-31 |
52244-0030 | Striant | Endo Pharmaceuticals Inc. | Yes | 2020-05-31 |
52244-0100 | Theo-24 | ENDO USA, Inc. | No | |
52244-0200 | Theo-24 | ENDO USA, Inc. | No | |
52244-0300 | Theo-24 | ENDO USA, Inc. | No | |
52244-0400 | Theo-24 | ENDO USA, Inc. | No | |
63481-0348 | Belbuca | Endo Pharmaceuticals, Inc. | Yes | 2018-10-31 |
63481-0519 | Belbuca | Endo Pharmaceuticals, Inc. | Yes | 2018-10-31 |
63481-0685 | Belbuca | Endo Pharmaceuticals, Inc. | Yes | 2018-10-31 |
63481-0820 | Belbuca | Endo Pharmaceuticals, Inc. | Yes | 2018-10-31 |
63481-0207 | Belbuca | Endo Pharmaceuticals, Inc. | Yes | 2018-10-31 |
63481-0161 | Belbuca | Endo Pharmaceuticals, Inc. | Yes | 2018-10-31 |
63481-0952 | Belbuca | Endo Pharmaceuticals, Inc. | Yes | 2018-10-31 |
63481-0421 | Coly-Mycin S | Endo Pharmaceuticals Inc. | Yes | 2020-04-30 |
63481-0529 | Cortisporin TC | Endo USA, Inc. | No | |
63481-0183 | FORTESTA | Endo Pharmaceuticals Inc. | Yes | No later than 2024-12-19 |
63481-0025 | FROVA | Endo USA, Inc. | No | |
63481-0687 | LIDODERM | Endo Pharmaceuticals Inc. | Yes | 2025-03-31 |
63481-0160 | Megace ES | Endo Pharmaceuticals Inc. | Yes | 2020-04-30 |
63481-0239 | Natesto | Endo Pharmaceuticals | Yes | 2018-05-31 |
63481-0624 | OPANA | Endo Pharmaceuticals Inc. | Yes | No later than 2017-12-29 |
63481-0613 | OPANA | Endo Pharmaceuticals Inc. | Yes | 2020-04-30 |
63481-0612 | OPANA | Endo Pharmaceuticals Inc. | Yes | 2020-03-31 |
63481-0812 | Opana ER | Endo Pharmaceuticals Inc. | Yes | 2020-02-01 |
63481-0813 | Opana ER | Endo Pharmaceuticals, Inc. | Yes | 2019-08-01 |
63481-0693 | OPANA ER | Endo Pharmaceuticals | Yes | No later than 2015-03-31 |
63481-0814 | Opana ER | Endo Pharmaceuticals Inc. | Yes | 2020-01-01 |
63481-0815 | Opana ER | Endo Pharmaceuticals Inc. | Yes | 2020-01-01 |
63481-0816 | Opana ER | Endo Pharmaceuticals, Inc. | Yes | 2019-08-01 |
63481-0817 | Opana ER | Endo Pharmaceuticals, Inc. | Yes | 2019-11-01 |
63481-0818 | Opana ER | Endo Pharmaceuticals, Inc. | Yes | 2019-07-01 |
63481-0907 | OPANA ER | Endo Pharmaceuticals | Yes | No later than 2015-03-31 |
63481-0674 | OPANA ER | Endo Pharmaceuticals | Yes | No later than 2015-03-31 |
63481-0617 | OPANA ER | Endo Pharmaceuticals | Yes | No later than 2015-03-31 |
63481-0434 | Opana ER | Endo Pharmaceuticals Inc. | Yes | No later than 2015-03-31 |
63481-0435 | Opana ER | Endo Pharmaceuticals Inc. | Yes | No later than 2015-03-31 |
63481-0436 | Opana ER | Endo Pharmaceuticals Inc. | Yes | No later than 2015-03-31 |
63481-0437 | Opana ER | Endo Pharmaceuticals Inc. | Yes | No later than 2015-03-31 |
63481-0438 | Opana ER | Endo Pharmaceuticals Inc. | Yes | No later than 2015-03-31 |
63481-0439 | Opana ER | Endo Pharmaceuticals Inc. | Yes | No later than 2015-03-31 |
63481-0440 | Opana ER | Endo Pharmaceuticals Inc. | Yes | No later than 2015-03-31 |
63481-0522 | OPANA ER | Endo Pharmaceuticals | Yes | No later than 2015-03-31 |
63481-0571 | OPANA ER | Endo Pharmaceuticals | Yes | No later than 2015-03-31 |
63481-0553 | OPANA ER | Endo Pharmaceuticals | Yes | No later than 2015-03-31 |
63481-0622 | PERCOCET | Endo Pharmaceuticals | Yes | 2013-12-31 |
63481-0621 | PERCOCET | Endo Pharmaceuticals | Yes | 2013-12-31 |
63481-0629 | PERCOCET | Endo USA, Inc. | No | |
63481-0628 | PERCOCET | Endo USA, Inc. | No | |
63481-0627 | PERCOCET | Endo USA, Inc. | Yes | 2025-11-30 |
63481-0623 | PERCOCET | Endo USA, Inc. | No | |
63481-0121 | PERCODAN | Endo Pharmaceuticals Inc | Yes | No later than 2015-12-16 |
63481-0367 | Sumavel DosePro | Endo Pharmaceuticals, Inc. | Yes | 2019-04-30 |
63481-0229 | Sumavel DosePro | Endo Pharmaceuticals | Yes | No later than 2018-03-29 |
63481-0684 | Voltaren | Endo Pharmaceuticals Inc. | Yes | 2022-04-30 |
63481-0698 | ZYDONE | Endo Pharmaceuticals Inc. | Yes | No later than 2014-03-31 |
63481-0669 | ZYDONE | Endo Pharmaceuticals Inc. | Yes | No later than 2014-03-31 |
63481-0668 | ZYDONE | Endo Pharmaceuticals Inc. | Yes | No later than 2014-03-31 |
66887-0005 | Dilatrate SR | Auxilium Pharmaceuticals, Inc. | Yes | No later than 2015-12-16 |
66887-0001 | Testim | Endo USA, Inc. | No | |
66887-0004 | Testopel | ENDO USA, Inc. | No | |
66887-0003 | XIAFLEX | ENDO USA, Inc. | No | |
67979-0511 | Aveed | ENDO USA, Inc. | No | |
67979-0501 | DELATESTRYL | Endo Pharmaceuticals Solutions Inc. | Yes | No later than 2017-04-03 |
67979-0002 | SUPPRELIN LA | ENDO USA, Inc. | No | |
67979-0001 | Valstar | Endo USA, Inc. | No | |
67979-0500 | Vantas | Endo Pharmaceuticals Inc. | Yes | 2022-03-31 |
Thank you for choosing Find-A-Code, please Sign In to remove ads.